Stryker
Worldwide Headquarters
2825 Airview Boulevard
Kalamazoo
Michigan
49002
United States
Tel: 269-385-2600
Fax: 269-385-1062
Website: http://www.stryker.com/
320 articles about Stryker
-
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
10/12/2022
Stryker, one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society annual meeting in Chicago, Oct. 12–15.
-
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
10/4/2022
Stryker announced the launch of the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion.
-
Stryker to host conference call on October 31, 2022
9/29/2022
Stryker announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update.
-
Stryker Launches Q Guidance System with Spine Guidance Software
9/27/2022
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today the launch of its Q Guidance System for spine applications.
-
The U.S. FDA had a busy week with a range of drug approvals, advisory committee meetings and classification announcements.
-
Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System
9/20/2022
Stryker announced today that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug Administration.
-
Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting
9/14/2022
Stryker (NYSE:SYK) today announced the launch of its Pulse Intelligent Delivery Platform, a full-circle product and fulfillment offering optimized for high volume foot and ankle procedures in the ambulatory surgery center (ASC) setting, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting (AOFAS).
-
Stryker Launches New Gamma4 Hip Fracture Nailing System
9/1/2022
Stryker has launched the Gamma4 System, strengthening the product’s 30-year legacy of continuous innovation and clinical history.
-
Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference
8/22/2022
Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022.
-
BioSpace spoke with Jay Johnson, the Director of Talent Acquisition for Orthopedics at Stryker, to find out what it takes to land a job in medical sales.
-
Stryker reports second quarter 2022 operating results
7/26/2022
Stryker (NYSE:SYK) reported operating results for the second quarter of 2022.
-
Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China
6/24/2022
Stryker, a leading medical technologies company, attended the 6th World Intelligence Congress in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market.
-
Stryker Receives FDA Clearance for Q Guidance System for Spine Applications
5/31/2022
Stryker (NYSE:SYK) today announced that its Q Guidance System received 510(k) clearance from the U.S. Food and Drug Administration.
-
Stryker Launches EasyFuse™ Dynamic Compression System for High-Demand Foot and Ankle Applications
5/25/2022
Stryker (NYSE:SYK) today announced the launch of its EasyFuse™ Dynamic Compression System.
-
Stryker announces board changes following Annual Meeting of Shareholders
5/5/2022
Stryker announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd to replace Ms. McCoy as Chair of the Governance and Nominating Committee.
-
Stryker's InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery
5/3/2022
Stryker (NYSE: SYK) announced today the publication of results from a multicenter, single-blinded, randomized controlled trial comparing Stryker's InSpace implant with partial repair for the treatment of full-thickness massive irreparable rotator cuff tears (MIRCTs) in the Journal of Bone and Joint Surgery (JBJS).
-
Stryker reports first quarter 2022 operating results
4/28/2022
We delivered solid first quarter results in the face of a challenging macroeconomic environment.
-
Stryker Launches Insignia® Hip Stem at the American Academy of Orthopaedic Surgeons (AAOS) 2022 Annual Meeting
3/22/2022
Stryker's Joint Replacement Division announced the introduction of the Insignia® Hip Stem, engineered to optimize patient fit and surgeon ease of implantation in muscle-sparing approaches for total hip and hemiarthroplasty procedures, at the American Academy of Orthopaedic Surgeons 2022 Annual Meeting in Chicago.
-
Stryker Launches PROstep™ MICA® SOLO Guide to Simplify Minimally Invasive Bunion Procedures
2/24/2022
Stryker Launches PROstep™ MICA ® SOLO Guide to Simplify Minimally Invasive Bunion Procedures.
-
Stryker to participate in Cowen 42nd Annual Health Care Conference
2/15/2022
Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation scheduled for 10:30 a.m. Eastern Time.